-
A Bayesian prevalence-incidence mixture model for screening outcomes with misclassification
Authors:
Thomas Klausch,
Birgit I. Lissenberg-Witte,
Veerle M. Coupé
Abstract:
We present BayesPIM, a Bayesian prevalence-incidence mixture model for estimating time- and covariate-dependent disease incidence from screening and surveillance data. The method is particularly suited to settings where some individuals may have the disease at baseline, baseline tests may be missing or incomplete, and the screening test has imperfect test sensitivity. This setting was present in d…
▽ More
We present BayesPIM, a Bayesian prevalence-incidence mixture model for estimating time- and covariate-dependent disease incidence from screening and surveillance data. The method is particularly suited to settings where some individuals may have the disease at baseline, baseline tests may be missing or incomplete, and the screening test has imperfect test sensitivity. This setting was present in data from high-risk colorectal cancer (CRC) surveillance through colonoscopy, where adenomas, precursors of CRC, were already present at baseline and remained undetected due to imperfect test sensitivity. By including covariates, the model can quantify heterogeneity in disease risk, thereby informing personalized screening strategies. Internally, BayesPIM uses a Metropolis-within-Gibbs sampler with data augmentation and weakly informative priors on the incidence and prevalence model parameters. In simulations based on the real-world CRC surveillance data, we show that BayesPIM estimates model parameters without bias while handling latent prevalence and imperfect test sensitivity. However, informative priors on the test sensitivity are needed to stabilize estimation and mitigate non-convergence issues. We also show how conditioning incidence and prevalence estimates on covariates explains heterogeneity in adenoma risk and how model fit is assessed using information criteria and a non-parametric estimator.
△ Less
Submitted 10 March, 2025; v1 submitted 20 December, 2024;
originally announced December 2024.
-
Fusion of Tree-induced Regressions for Clinico-genomic Data
Authors:
Jeroen M. Goedhart,
Mark A. van de Wiel,
Wessel N. van Wieringen,
Thomas Klausch
Abstract:
Cancer prognosis is often based on a set of omics covariates and a set of established clinical covariates such as age and tumor stage. Combining these two sets poses challenges. First, dimension difference: clinical covariates should be favored because they are low-dimensional and usually have stronger prognostic ability than high-dimensional omics covariates. Second, interactions: genetic profile…
▽ More
Cancer prognosis is often based on a set of omics covariates and a set of established clinical covariates such as age and tumor stage. Combining these two sets poses challenges. First, dimension difference: clinical covariates should be favored because they are low-dimensional and usually have stronger prognostic ability than high-dimensional omics covariates. Second, interactions: genetic profiles and their prognostic effects may vary across patient subpopulations. Last, redundancy: a (set of) gene(s) may encode similar prognostic information as a clinical covariate. To address these challenges, we combine regression trees, employing clinical covariates only, with a fusion-like penalized regression framework in the leaf nodes for the omics covariates. The fusion penalty controls the variability in genetic profiles across subpopulations. We prove that the shrinkage limit of the proposed method equals a benchmark model: a ridge regression with penalized omics covariates and unpenalized clinical covariates. Furthermore, the proposed method allows researchers to evaluate, for different subpopulations, whether the overall omics effect enhances prognosis compared to only employing clinical covariates. In an application to colorectal cancer prognosis based on established clinical covariates and 20,000+ gene expressions, we illustrate the features of our method.
△ Less
Submitted 4 November, 2024;
originally announced November 2024.
-
A Semi-supervised CART Model for Covariate Shift
Authors:
Mingyang Cai,
Thomas Klausch,
Mark A. van de Wiel
Abstract:
Machine learning models used in medical applications often face challenges due to the covariate shift, which occurs when there are discrepancies between the distributions of training and target data. This can lead to decreased predictive accuracy, especially with unknown outcomes in the target data. This paper introduces a semi-supervised classification and regression tree (CART) that uses importa…
▽ More
Machine learning models used in medical applications often face challenges due to the covariate shift, which occurs when there are discrepancies between the distributions of training and target data. This can lead to decreased predictive accuracy, especially with unknown outcomes in the target data. This paper introduces a semi-supervised classification and regression tree (CART) that uses importance weighting to address these distribution discrepancies. Our method improves the predictive performance of the CART model by assigning greater weights to training samples that more accurately represent the target distribution, especially in cases of covariate shift without target outcomes. In addition to CART, we extend this weighted approach to generalized linear model trees and tree ensembles, creating a versatile framework for managing the covariate shift in complex datasets. Through simulation studies and applications to real-world medical data, we demonstrate significant improvements in predictive accuracy. These findings suggest that our weighted approach can enhance reliability in medical applications and other fields where the covariate shift poses challenges to model performance across various data distributions.
△ Less
Submitted 22 December, 2024; v1 submitted 28 October, 2024;
originally announced October 2024.
-
Seemingly unrelated Bayesian additive regression trees for cost-effectiveness analyses in healthcare
Authors:
Jonas Esser,
Mateus Maia,
Andrew C. Parnell,
Judith Bosmans,
Hanneke van Dongen,
Thomas Klausch,
Keefe Murphy
Abstract:
In recent years, theoretical results and simulation evidence have shown Bayesian additive regression trees to be a highly-effective method for nonparametric regression. Motivated by cost-effectiveness analyses in health economics, where interest lies in jointly modelling the costs of healthcare treatments and the associated health-related quality of life experienced by a patient, we propose a mult…
▽ More
In recent years, theoretical results and simulation evidence have shown Bayesian additive regression trees to be a highly-effective method for nonparametric regression. Motivated by cost-effectiveness analyses in health economics, where interest lies in jointly modelling the costs of healthcare treatments and the associated health-related quality of life experienced by a patient, we propose a multivariate extension of BART which is applicable in regression analyses with several dependent outcome variables. Our framework allows for continuous or binary outcomes and overcomes some key limitations of existing multivariate BART models by allowing each individual response to be associated with different ensembles of trees, while still handling dependencies between the outcomes. In the case of continuous outcomes, our model is essentially a nonparametric version of seemingly unrelated regression. Likewise, our proposal for binary outcomes is a nonparametric generalisation of the multivariate probit model. We give suggestions for easily interpretable prior distributions, which allow specification of both informative and uninformative priors. We provide detailed discussions of MCMC sampling methods to conduct posterior inference. Our methods are implemented in the R package "subart". We showcase their performance through extensive simulation experiments and an application to an empirical case study from health economics. By also accommodating propensity scores in a manner befitting a causal analysis, we find substantial evidence for a novel trauma care intervention's cost-effectiveness.
△ Less
Submitted 26 February, 2025; v1 submitted 2 April, 2024;
originally announced April 2024.
-
Co-data Learning for Bayesian Additive Regression Trees
Authors:
Jeroen M. Goedhart,
Thomas Klausch,
Jurriaan Janssen,
Mark A. van de Wiel
Abstract:
Medical prediction applications often need to deal with small sample sizes compared to the number of covariates. Such data pose problems for prediction and variable selection, especially when the covariate-response relationship is complicated. To address these challenges, we propose to incorporate co-data, i.e. external information on the covariates, into Bayesian additive regression trees (BART),…
▽ More
Medical prediction applications often need to deal with small sample sizes compared to the number of covariates. Such data pose problems for prediction and variable selection, especially when the covariate-response relationship is complicated. To address these challenges, we propose to incorporate co-data, i.e. external information on the covariates, into Bayesian additive regression trees (BART), a sum-of-trees prediction model that utilizes priors on the tree parameters to prevent overfitting. To incorporate co-data, an empirical Bayes (EB) framework is developed that estimates, assisted by a co-data model, prior covariate weights in the BART model. The proposed method can handle multiple types of co-data simultaneously. Furthermore, the proposed EB framework enables the estimation of the other hyperparameters of BART as well, rendering an appealing alternative to cross-validation. We show that the method finds relevant covariates and that it improves prediction compared to default BART in simulations. If the covariate-response relationship is nonlinear, the method benefits from the flexibility of BART to outperform regression-based co-data learners. Finally, the use of co-data enhances prediction in an application to diffuse large B-cell lymphoma prognosis based on clinical covariates, gene mutations, DNA translocations, and DNA copy number data.
Keywords: Bayesian additive regression trees; Empirical Bayes; Co-data; High-dimensional data; Omics; Prediction
△ Less
Submitted 3 November, 2024; v1 submitted 16 November, 2023;
originally announced November 2023.
-
Estimation of Predictive Performance in High-Dimensional Data Settings using Learning Curves
Authors:
Jeroen M. Goedhart,
Thomas Klausch,
Mark A. van de Wiel
Abstract:
In high-dimensional prediction settings, it remains challenging to reliably estimate the test performance. To address this challenge, a novel performance estimation framework is presented. This framework, called Learn2Evaluate, is based on learning curves by fitting a smooth monotone curve depicting test performance as a function of the sample size. Learn2Evaluate has several advantages compared t…
▽ More
In high-dimensional prediction settings, it remains challenging to reliably estimate the test performance. To address this challenge, a novel performance estimation framework is presented. This framework, called Learn2Evaluate, is based on learning curves by fitting a smooth monotone curve depicting test performance as a function of the sample size. Learn2Evaluate has several advantages compared to commonly applied performance estimation methodologies. Firstly, a learning curve offers a graphical overview of a learner. This overview assists in assessing the potential benefit of adding training samples and it provides a more complete comparison between learners than performance estimates at a fixed subsample size. Secondly, a learning curve facilitates in estimating the performance at the total sample size rather than a subsample size. Thirdly, Learn2Evaluate allows the computation of a theoretically justified and useful lower confidence bound. Furthermore, this bound may be tightened by performing a bias correction. The benefits of Learn2Evaluate are illustrated by a simulation study and applications to omics data.
△ Less
Submitted 8 June, 2022;
originally announced June 2022.
-
A Bayesian accelerated failure time model for interval censored three-state screening outcomes
Authors:
Thomas Klausch,
Eddymurphy U. Akwiwu,
Mark A. van de Wiel,
Veerle M. H. Coupe,
Johannes Berkhof
Abstract:
Women infected by the Human papilloma virus are at an increased risk to develop cervical intraepithalial neoplasia lesions (CIN). CIN are classified into three grades of increasing severity (CIN-1, CIN-2, and CIN-3) and can eventually develop into cervical cancer. The main purpose of screening is detecting CIN-2 and CIN-3 cases which are usually surgically removed. Screening data from the POBASCAM…
▽ More
Women infected by the Human papilloma virus are at an increased risk to develop cervical intraepithalial neoplasia lesions (CIN). CIN are classified into three grades of increasing severity (CIN-1, CIN-2, and CIN-3) and can eventually develop into cervical cancer. The main purpose of screening is detecting CIN-2 and CIN-3 cases which are usually surgically removed. Screening data from the POBASCAM trial involving 1,454 HPV-positive women is analyzed with two objectives: estimate (a) the transition time from HPV diagnosis to CIN-3; and (b) the transition time from CIN-2 to CIN-3. The screening data have two key characteristics. First, the CIN state is monitored in an interval-censored sequence of screening times. Second, a woman's progression to CIN-3 is only observed, if the woman progresses to, both, CIN-2 and from CIN-2 to CIN-3 in the same screening interval. We propose a Bayesian accelerated failure time model for the two transition times in this three-state model. To deal with the unusual censoring structure of the screening data, we develop a Metropolis-within-Gibbs algorithm with data augmentation from the truncated transition time distributions.
△ Less
Submitted 3 December, 2021; v1 submitted 6 October, 2021;
originally announced October 2021.
-
Estimating Bayesian Optimal Treatment Regimes for Dichotomous Outcomes using Observational Data
Authors:
Thomas Klausch,
Peter van de Ven,
Tim van de Brug,
Mark A. van de Wiel,
Johannes Berkhof
Abstract:
Optimal treatment regimes (OTR) are individualised treatment assignment strategies that identify a medical treatment as optimal given all background information available on the individual. We discuss Bayes optimal treatment regimes estimated using a loss function defined on the bivariate distribution of dichotomous potential outcomes. The proposed approach allows considering more general objectiv…
▽ More
Optimal treatment regimes (OTR) are individualised treatment assignment strategies that identify a medical treatment as optimal given all background information available on the individual. We discuss Bayes optimal treatment regimes estimated using a loss function defined on the bivariate distribution of dichotomous potential outcomes. The proposed approach allows considering more general objectives for the OTR than maximization of an expected outcome (e.g., survival probability) by taking into account, for example, unnecessary treatment burden. As a motivating example we consider the case of oropharynx cancer treatment where unnecessary burden due to chemotherapy is to be avoided while maximizing survival chances. Assuming ignorable treatment assignment we describe Bayesian inference about the OTR including a sensitivity analysis on the unobserved partial association of the potential outcomes. We evaluate the methodology by simulations that apply Bayesian parametric and more flexible non-parametric outcome models. The proposed OTR for oropharynx cancer reduces the frequency of the more burdensome chemotherapy assignment by approximately 75% without reducing the average survival probability. This regime thus offers a strong increase in expected quality of life of patients.
△ Less
Submitted 28 September, 2018; v1 submitted 18 September, 2018;
originally announced September 2018.
